Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Murrough

Showing results (51-60 of 173) with videos related to

Pageof 18
Sort By:
The American Journal of Psychiatry|December 6, 2012
ECT in treatment-resistant depressionCharles H Kellner, Robert M Greenberg, James W Murrough, et al.
Journal of Affective Disorders|November 17, 2015
Cortical abnormalities and association with symptom dimensions across the depressive spectrumMarc S Lener, Prantik Kundu, Edmund Wong, et al.
Translational Psychiatry|February 17, 2019
Ultra-high field MRI reveals mood-related circuit disturbances in depression: a comparison between 3-Tesla and 7-TeslaLaurel S Morris, Prantik Kundu, Sara Costi, et al.
Psychopharmacology|May 19, 2010
Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorderJames W Murrough, Shannan Henry, Jian Hu, et al.
The International Journal of Neuropsychopharmacology|March 18, 2009
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trialSanjay J Mathew, James W Murrough, Marije aan het Rot, et al.
Neuroscience Letters|April 8, 2014
In vivo (1)H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorderKyle A B Lapidus, Vilma Gabbay, Xiangling Mao, et al.
Focus (American Psychiatric Publishing)|October 25, 2021
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment OptionsAmir Garakani, James W Murrough, Rafael C Freire, et al.
Neuroimage. Clinical|January 6, 2020
Neural correlates of rumination in major depressive disorder: A brain network analysisYael Jacob, Laurel S Morris, Kuang-Han Huang, et al.
Frontiers in Psychiatry|January 11, 2021
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment OptionsAmir Garakani, James W Murrough, Rafael C Freire, et al.
Journal of Occupational and Environmental Medicine|December 22, 2021
Effects of Sleep, Exercise, and Leadership Support on Resilience in Frontline Healthcare Workers During the COVID-19 PandemicHalley Kaye-Kauderer, George Loo, James W Murrough, et al.
Pageof 18

Showing results (51-60 of 173) with videos related to

Sort By:
Pageof 18
The American Journal of Psychiatry|December 6, 2012
ECT in treatment-resistant depressionCharles H Kellner, Robert M Greenberg, James W Murrough, et al.
Journal of Affective Disorders|November 17, 2015
Cortical abnormalities and association with symptom dimensions across the depressive spectrumMarc S Lener, Prantik Kundu, Edmund Wong, et al.
Translational Psychiatry|February 17, 2019
Ultra-high field MRI reveals mood-related circuit disturbances in depression: a comparison between 3-Tesla and 7-TeslaLaurel S Morris, Prantik Kundu, Sara Costi, et al.
Psychopharmacology|May 19, 2010
Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorderJames W Murrough, Shannan Henry, Jian Hu, et al.
The International Journal of Neuropsychopharmacology|March 18, 2009
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trialSanjay J Mathew, James W Murrough, Marije aan het Rot, et al.
Neuroscience Letters|April 8, 2014
In vivo (1)H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorderKyle A B Lapidus, Vilma Gabbay, Xiangling Mao, et al.
Focus (American Psychiatric Publishing)|October 25, 2021
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment OptionsAmir Garakani, James W Murrough, Rafael C Freire, et al.
Neuroimage. Clinical|January 6, 2020
Neural correlates of rumination in major depressive disorder: A brain network analysisYael Jacob, Laurel S Morris, Kuang-Han Huang, et al.
Frontiers in Psychiatry|January 11, 2021
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment OptionsAmir Garakani, James W Murrough, Rafael C Freire, et al.
Journal of Occupational and Environmental Medicine|December 22, 2021
Effects of Sleep, Exercise, and Leadership Support on Resilience in Frontline Healthcare Workers During the COVID-19 PandemicHalley Kaye-Kauderer, George Loo, James W Murrough, et al.
Pageof 18